- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/16 - Purine radicals
Patent holdings for IPC class C07H 19/16
Total number of patents in this class: 777
10-year publication summary
|
81
|
67
|
72
|
73
|
83
|
61
|
61
|
46
|
30
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Atea Pharmaceuticals, Inc. | 75 |
25 |
| Illumina Cambridge Limited | 678 |
23 |
| Gilead Sciences, Inc. | 2038 |
15 |
| Epizyme, Inc. | 373 |
14 |
| The Trustees of Columbia University in the City of New York | 3577 |
13 |
| Janssen Biopharma, Inc. | 40 |
13 |
| Idenix Pharmaceuticals LLC | 62 |
12 |
| Osaka University | 3377 |
12 |
| Centre National de La Recherche Scientifique | 10442 |
11 |
| Dana-Farber Cancer Institute, Inc. | 2568 |
11 |
| Emory University | 1631 |
11 |
| The Scripps Research Institute | 1350 |
11 |
| Merck Sharp & Dohme Corp. | 2190 |
9 |
| Arcus Biosciences, Inc. | 139 |
9 |
| Roche Innovation Center Copenhagen A/S | 134 |
9 |
| Janssen Pharmaceuticals, Inc. | 427 |
8 |
| Idenix Pharmaceuticals, Inc. | 47 |
8 |
| Ionis Pharmaceuticals, Inc. | 869 |
8 |
| The Regents of the University of California | 19943 |
7 |
| Janssen Pharmaceutica N.V. | 3384 |
7 |
| Other owners | 541 |